1-20 of 20
brain natriuretic peptide
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes

Tina Costacou, Amy K. Saenger, Trevor J. Orchard
Journal: Diabetes Care
Diabetes Care 2020;43(9):2199–2207
https://doi.org/10.2337/dc20-0359
Published: 02 July 2020
View article titled, High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes
Open the PDF for High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes in another window
Journal Articles

Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial

Petr Jarolim, William B. White, Christopher P. Cannon, Qi Gao, David A. Morrow
Journal: Diabetes Care
Diabetes Care 2018;41(7):1510–1515
https://doi.org/10.2337/dc18-0109
Published: 30 May 2018
View article titled, Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial
Open the PDF for Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial in another window
Includes: Supplementary data
Journal Articles

Comment on Ferrannini et al. CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis. Diabetes Care 2016;39:1108–1114

Jens Jordan, Ali El-Armouche, Markolf Hanefeld, Stefan R. Bornstein, Andreas L. Birkenfeld
Journal: Diabetes Care
Diabetes Care 2016;39(12):e224–e225
https://doi.org/10.2337/dc16-1588
Published: 10 November 2016
View article titled, Comment on Ferrannini et al. CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis. Diabetes Care 2016;39:1108–1114
Open the PDF for Comment on Ferrannini et al. CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis. Diabetes Care 2016;39:1108–1114 in another window
Journal Articles

Natriuretic Peptides, Heart, and Adipose Tissue: New Findings and Future Developments for Diabetes Research

Gabriella Gruden, Andrea Landi, Graziella Bruno
Journal: Diabetes Care
Diabetes Care 2014;37(11):2899–2908
https://doi.org/10.2337/dc14-0669
Published: 10 October 2014
View article titled, Natriuretic Peptides, Heart, and Adipose Tissue: New Findings and Future Developments for Diabetes Research
Open the PDF for Natriuretic Peptides, Heart, and Adipose Tissue: New Findings and Future Developments for Diabetes Research in another window
Journal Articles

Changes in B-Type Natriuretic Peptide and BMI Following Roux-en-Y Gastric Bypass Surgery

Annis M. Marney, Nancy J. Brown, Robyn Tamboli, Naji Abumrad
Journal: Diabetes Care
Diabetes Care 2014;37(4):e70–e71
https://doi.org/10.2337/dc13-2449
Published: 08 March 2014
View article titled, Changes in B-Type Natriuretic Peptide and BMI Following Roux-en-Y Gastric Bypass Surgery
Open the PDF for Changes in B-Type Natriuretic Peptide and BMI Following Roux-en-Y Gastric Bypass Surgery in another window
Journal Articles

Aldosterone, C-Reactive Protein, and Plasma B-Type Natriuretic Peptide Are Associated With the Development of Metabolic Syndrome and Longitudinal Changes in Metabolic Syndrome Components: Findings from the Jackson Heart Study

Solomon K. Musani, PHD, Ramachandran S. Vasan, MD, Aurelian Bidulescu, MD, Jiankang Liu, MD, Vanessa Xanthakis, PHD, Mario Sims, PHD, Ravi K. Gawalapu, PHD, Tandaw E. Samdarshi, MD, Michael Steffes, MD, Herman A. Taylor, MD, Ervin R. Fox, MD
Journal: Diabetes Care
Diabetes Care 2013;36(10):3084–3092
https://doi.org/10.2337/dc12-2562
Published: 14 September 2013
View article titled, Aldosterone, C-Reactive Protein, and Plasma B-Type Natriuretic Peptide Are Associated With the Development of Metabolic Syndrome and Longitudinal Changes in Metabolic Syndrome Components: <subtitle>Findings from the Jackson Heart Study</subtitle>
Open the PDF for Aldosterone, C-Reactive Protein, and Plasma B-Type Natriuretic Peptide Are Associated With the Development of Metabolic Syndrome and Longitudinal Changes in Metabolic Syndrome Components: <subtitle>Findings from the Jackson Heart Study</subtitle> in another window
Includes: Supplementary data
Journal Articles

The Atrial Natriuretic Peptide Genetic Variant rs5068 Is Associated With a Favorable Cardiometabolic Phenotype in a Mediterranean Population

Valentina Cannone, MD, Angelo Baldassare Cefalu’, MD, Davide Noto, MD, Christopher G. Scott, MS, Kent R. Bailey, PHD, Giovanni Cavera, MD, Michele Pagano, MD, Michelangelo Sapienza, MD, Maurizio R. Averna, MD, John C. Burnett, Jr., MD
Journal: Diabetes Care
Diabetes Care 2013;36(9):2850–2856
https://doi.org/10.2337/dc12-2337
Published: 13 August 2013
View article titled, The Atrial Natriuretic Peptide Genetic Variant rs5068 Is Associated With a Favorable Cardiometabolic Phenotype in a Mediterranean Population
Open the PDF for The Atrial Natriuretic Peptide Genetic Variant rs5068 Is Associated With a Favorable Cardiometabolic Phenotype in a Mediterranean Population in another window
Journal Articles

Prospective Associations of B-Type Natriuretic Peptide With Markers of Left Ventricular Function in Individuals With and Without Type 2 Diabetes: An 8-year follow-up of the Hoorn Study

Maria H. Kroon, MSC, Katja van den Hurk, PHD, Marjan Alssema, PHD, Otto Kamp, MD, Coen D.A. Stehouwer, MD, Ronald M.A. Henry, MD, Michaela Diamant, MD, Frans Boomsma, PHD, Giel Nijpels, MD, Walter J. Paulus, MD, Jacqueline M. Dekker, PHD
Journal: Diabetes Care
Diabetes Care 2012;35(12):2510–2514
https://doi.org/10.2337/dc11-1959
Published: 14 November 2012
View article titled, Prospective Associations of B-Type Natriuretic Peptide With Markers of Left Ventricular Function in Individuals With and Without Type 2 Diabetes: <subtitle>An 8-year follow-up of the Hoorn Study</subtitle>
Open the PDF for Prospective Associations of B-Type Natriuretic Peptide With Markers of Left Ventricular Function in Individuals With and Without Type 2 Diabetes: <subtitle>An 8-year follow-up of the Hoorn Study</subtitle> in another window
Journal Articles

Circulating CD34-Positive Cell Number Is Associated With Brain Natriuretic Peptide Level in Type 2 Diabetic Patients

Sadanori Okada, MD, Hisashi Makino, MD, PHD, Ayako Nagumo, MD, Takako Sugisawa, MD, PHD, Muneya Fujimoto, MD, PHD, Ichiro Kishimoto, MD, PHD, Yoshihiro Miyamoto, MD, PHD, Akie Kikuchi-Taura, Toshihiro Soma, MD, Akihiko Taguchi, MD, PHD, Yasunao Yoshimasa, MD, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(1):157–158
https://doi.org/10.2337/dc07-1125
Published: 01 January 2008
View article titled, Circulating CD34-Positive Cell Number Is Associated With Brain Natriuretic Peptide Level in Type 2 Diabetic Patients
Open the PDF for Circulating CD34-Positive Cell Number Is Associated With Brain Natriuretic Peptide Level in Type 2 Diabetic Patients in another window
Journal Articles

Amino-Terminal Brain Natriuretic Peptide is Related to the Presence of Diabetic Polyneuropathy Independently of Cardiovascular Disease

Jeroni Jurado, RN, DNS, Juan Ybarra, MD, PHD, Maria Ferrandiz, MD, Lourdes Comerma, RN, Jose Maria Pou, MD, PHD
Journal: Diabetes Care
Diabetes Care 2007;30(8):e86
https://doi.org/10.2337/dc07-0890
Published: 01 August 2007
View article titled, Amino-Terminal Brain Natriuretic Peptide is Related to the Presence of Diabetic Polyneuropathy Independently of Cardiovascular Disease
Open the PDF for Amino-Terminal Brain Natriuretic Peptide is Related to the Presence of Diabetic Polyneuropathy Independently of Cardiovascular Disease in another window
Journal Articles

Prognostic Value of NH2-Terminal Pro B-Type Natriuretic Peptide in Patients With Diabetes and Stable Coronary Heart Disease

Charlotte Kragelund, MD, Ida Gustafsson, MD, PHD, Torbjørn Omland, MD, PHD, MPH, Bjørn Grønning, MD, Lars Køber, MD, DMSC, Jens Faber, MD, DMSC, Søren Strande, MD, Rolf Steffensen, MD, Per Hildebrandt, MD, DMSC
Journal: Diabetes Care
Diabetes Care 2006;29(6):1411–1413
https://doi.org/10.2337/dc06-0227
Published: 01 June 2006
View article titled, Prognostic Value of NH<sub>2</sub>-Terminal Pro B-Type Natriuretic Peptide in Patients With Diabetes and Stable Coronary Heart Disease
Open the PDF for Prognostic Value of NH<sub>2</sub>-Terminal Pro B-Type Natriuretic Peptide in Patients With Diabetes and Stable Coronary Heart Disease in another window
Journal Articles

Errata

Journal: Diabetes Care
Diabetes Care 2005;28(6):1542
https://doi.org/10.2337/diacare.28.6.1542
Published: 01 June 2005
View article titled, Errata
Open the PDF for Errata in another window
Journal Articles

The European Association for the Study of Diabetes

Zachary T. Bloomgarden, MD
Journal: Diabetes Care
Diabetes Care 2005;28(5):1250–1257
https://doi.org/10.2337/diacare.28.5.1250
Published: 01 May 2005
View article titled, The European Association for the Study of Diabetes
Open the PDF for The European Association for the Study of Diabetes in another window
Journal Articles

B-Type Natriuretic Peptide in Type 2 Diabetes: The influence of chronic renal failure and food

Liu Chung, MD, Agnès Georges, PHARMD, Jean Benoit Corcuff, MD, PHD, Laurence Bordenave, MD, PHD, Henri Gin, MD, PHD, Vincent Rigalleau, MD, PHD
Journal: Diabetes Care
Diabetes Care 2005;28(3):752
https://doi.org/10.2337/diacare.28.3.752
Published: 01 March 2005
View article titled, B-Type Natriuretic Peptide in Type 2 Diabetes: <subtitle>The influence of chronic renal failure and food</subtitle>
Open the PDF for B-Type Natriuretic Peptide in Type 2 Diabetes: <subtitle>The influence of chronic renal failure and food</subtitle> in another window
Journal Articles

The Effect of Diabetes on B-Type Natriuretic Peptide Concentrations in Patients With Acute Dyspnea: An analysis from the Breathing Not Properly Multinational Study

Alan H.B. Wu, PHD, Torbjørn Omland, MD, PHD, MPH, Philippe Duc, MD, James McCord, MD, Richard M. Nowak, MD, MBA, Judd E. Hollander, MD, Howard C. Herrmann, MD, Philippe G. Steg, MD, Cathrine Wold Knudsen, MD, Alan B. Storrow, MD, William T. Abraham, MD, Alberto Perez, MD, Richard Kamin, MD, Paul Clopton, MSC, MD, Alan S. Maisel, MD, Peter A. McCullough, MD, for the Breathing Not Properly Multinational Study Investigators
Journal: Diabetes Care
Diabetes Care 2004;27(10):2398–2404
https://doi.org/10.2337/diacare.27.10.2398
Published: 01 October 2004
View article titled, The Effect of Diabetes on B-Type Natriuretic Peptide Concentrations in Patients With Acute Dyspnea: <subtitle>An analysis from the Breathing Not Properly Multinational Study</subtitle>
Open the PDF for The Effect of Diabetes on B-Type Natriuretic Peptide Concentrations in Patients With Acute Dyspnea: <subtitle>An analysis from the Breathing Not Properly Multinational Study</subtitle> in another window
Journal Articles

Elevated Plasma Levels of Nt-proBNP in Patients With Type 2 Diabetes Without Overt Cardiovascular Disease

Martin Magnusson, MD, Olle Melander, MD, PHD, Bo Israelsson, MD, PHD, Anders Grubb, MD, PHD, Leif Groop, MD, PHD, Stefan Jovinge, MD, PHD
Journal: Diabetes Care
Diabetes Care 2004;27(8):1929–1935
https://doi.org/10.2337/diacare.27.8.1929
Published: 01 August 2004
View article titled, Elevated Plasma Levels of Nt-proBNP in Patients With Type 2 Diabetes Without Overt Cardiovascular Disease
Open the PDF for Elevated Plasma Levels of Nt-proBNP in Patients With Type 2 Diabetes Without Overt Cardiovascular Disease in another window
Journal Articles

Utility of B-Type Natriuretic Peptide as a Screen for Left Ventricular Dysfunction in Patients With Diabetes : Response to Liew et al.

Robert R. Henry, MD, Alan Maisel, MD
Journal: Diabetes Care
Diabetes Care 2004;27(3):848–849
https://doi.org/10.2337/diacare.27.3.848-a
Published: 01 March 2004
View article titled, Utility of B-Type Natriuretic Peptide as a Screen for Left Ventricular Dysfunction in Patients With Diabetes : <subtitle>Response to Liew et al.</subtitle>
Open the PDF for Utility of B-Type Natriuretic Peptide as a Screen for Left Ventricular Dysfunction in Patients With Diabetes : <subtitle>Response to Liew et al.</subtitle> in another window
Journal Articles

Utility of B-Type Natriuretic Peptide as a Screen for Left Ventricular Dysfunction in Patients With Diabetes : Response to Epshteyn et al.

Danny Liew, FRACP, Hans Schneider, FRACP, Joe D’Agostino, BSC, Jonathan Shaw, MD, Henry Krum, PHD
Journal: Diabetes Care
Diabetes Care 2004;27(3):848
https://doi.org/10.2337/diacare.27.3.848
Published: 01 March 2004
View article titled, Utility of B-Type Natriuretic Peptide as a Screen for Left Ventricular Dysfunction in Patients With Diabetes : <subtitle>Response to Epshteyn et al.</subtitle>
Open the PDF for Utility of B-Type Natriuretic Peptide as a Screen for Left Ventricular Dysfunction in Patients With Diabetes : <subtitle>Response to Epshteyn et al.</subtitle> in another window
Journal Articles

Utility of B-Type Natriuretic Peptide (BNP) as a Screen for Left Ventricular Dysfunction in Patients With Diabetes

Victoria Epshteyn, BA, Katherine Morrison, BA, Padma Krishnaswamy, MD, Radmila Kazanegra, MD, Paul Clopton, MS, Sunder Mudaliar, MD, Steven Edelman, MD, Robert Henry, MD, Alan Maisel, MD, FACC
Journal: Diabetes Care
Diabetes Care 2003;26(7):2081–2087
https://doi.org/10.2337/diacare.26.7.2081
Published: 01 July 2003
View article titled, Utility of B-Type Natriuretic Peptide (BNP) as a Screen for Left Ventricular Dysfunction in Patients With Diabetes
Open the PDF for Utility of B-Type Natriuretic Peptide (BNP) as a Screen for Left Ventricular Dysfunction in Patients With Diabetes in another window
Journal Articles

Brain Natriuretic Peptide as a Potential Marker of Diastolic Dysfunction in Type 2 Diabetes

N. Norman Chan, MRCP, DCH, Steven J. Hurel, PHD, MRCP
Journal: Diabetes Care
Diabetes Care 2001;24(11):2019–2020
https://doi.org/10.2337/diacare.24.11.2019
Published: 01 November 2001
View article titled, Brain Natriuretic Peptide as a Potential Marker of Diastolic Dysfunction in Type 2 Diabetes
Open the PDF for Brain Natriuretic Peptide as a Potential Marker of Diastolic Dysfunction in Type 2 Diabetes in another window